AstraZeneca announced the reason for recalling COVID-19 vaccine

AstraZeneca said it has begun recalling COVID-19 vaccines worldwide due to 'a surplus of updated vaccines available' since the pandemic.

The announcement was made by the British-Swedish pharmaceutical company on May 7, applying to the Vaxzevria vaccine (AZD1222) produced in collaboration with Oxford University (UK), often known to the public as "vaccine". COVID-19 AstraZeneca".

Astrazeneca also said they will withdraw the license to market this vaccine in Europe, according to Reuters.

AstraZeneca begins to recall COVID-19 vaccine - (Photo: REUTERS).

According to the pharmaceutical company, this decision was made because the market currently has many updated COVID-19 vaccines based on new variants, leading to a surplus and reduced demand for AstraZeneca's vaccine.

According to the Telegraph, the first newspaper to report this development, the company's application to withdraw the vaccine was made on March 5 and took effect on May 7.

Previously, this pharmaceutical company made headlines when it admitted in court documents that its COVID-19 vaccine could cause rare side effects such as thrombosis (blood clots) and thrombocytopenia.

However, according to detailed studies, this effect is limited to the first few days after injection.

An Australian Department of Health statistic based on domestic data shows that the risk of thrombotic and thrombocytopenic side effects usually only lasts for 4-42 days after the first dose; The risk rate is 2/100,000 in people over 60 years old and 2-3/100,000 in people under 60 years old.

AstraZeneca (headquartered in London - England) began turning to production of respiratory syncytial virus vaccines and obesity drugs last year after growth slowed due to sales of COVID-related products. 19 decrease.